Brian Harris
Overview
Explore the profile of Brian Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enlow E, Diba M, Clayton J, Harris B, Abbaszadeh S
IEEE Trans Radiat Plasma Med Sci
. 2024 Mar;
7(6):580-586.
PMID: 38468608
Cadmium zinc telluride (CZT) detectors enable high spatial resolution and high detection efficiency and are utilized for many gamma-ray and X-ray spectroscopy applications. In this article, we describe a stable...
2.
Smayda K, Campellone T, Taylor S, Harris B, Ellis T, Awad L
Front Digit Health
. 2023 Oct;
5:1261124.
PMID: 37818169
No abstract available.
3.
Collimore A, Cataldo A, Aiello A, Sloutsky R, Hutchinson K, Harris B, et al.
Neurorehabil Neural Repair
. 2023 Jun;
37(5):255-265.
PMID: 37272500
Background: Post-stroke care guidelines highlight continued rehabilitation as essential; however, many stroke survivors cannot participate in outpatient rehabilitation. Technological advances in wearable sensing, treatment algorithms, and care delivery interfaces have...
4.
Hutchinson K, Sloutsky R, Collimore A, Adams B, Harris B, Ellis T, et al.
Neurorehabil Neural Repair
. 2020 Oct;
34(11):986-996.
PMID: 33040685
Background: The rhythm of music can entrain neurons in motor cortex by way of direct connections between auditory and motor brain regions. Objective: We sought to automate an individualized and...
5.
Zhao Z, Harris B, Hu Y, Harmon T, Pentel P, Ehrich M, et al.
Biomaterials
. 2017 Nov;
155:165-175.
PMID: 29179132
Current clinically-tested nicotine vaccines have yet shown enhanced smoking cessation efficacy due to their low immunogenicity. Achieving a sufficiently high immunogenicity is a necessity for establishing a clinically-viable nicotine vaccine....
6.
Schnakers C, Magee W, Harris B
Front Psychol
. 2016 Mar;
7:297.
PMID: 27014119
No abstract available.
7.
8.
Robbie G, Makari D, Harris B, Losonsky G, Jafri H
Infect Dis Ther
. 2014 Oct;
3(2):203-14.
PMID: 25269648
Objective: To assess the pharmacokinetics and safety of liquid palivizumab compared with lyophilized palivizumab. Methods: This phase 2, randomized, double-blind crossover study included premature infants aged ≤6 months born ≤35 ...
9.
Makari D, Jensen K, Harris B, Jafri H
Infect Dis Ther
. 2014 Aug;
3(2):339-47.
PMID: 25156956
Introduction: To avoid the need for reconstitution required by lyophilized palivizumab, a liquid formulation was developed. This study assessed the safety and antidrug antibodies (ADA) of the liquid formulation of...
10.
Pritchard D, Hoerger M, Mace F, Penney H, Harris B
J Exp Anal Behav
. 2014 Apr;
101(3):442-9.
PMID: 24700533
Behavioral Momentum Theory (BMT) has inspired animal models of treatment relapse. We translated the models of reinstatement and resurgence into clinical procedures to test whether relapse tests would replicate behavior...